Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Endocrinology Research Centre 2018-12-01
Reeks:Ожирение и метаболизм
Onderwerpen:
diabetes type 2
obesity
glucagon-like peptide-1 receptor agonists
glucagon-like peptide-1
ghrelin
food behavior
Online toegang:https://www.omet-endojournals.ru/jour/article/view/9584
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items